• Biovica expanded a Master Services Agreement with an existing customer, described as a leading global pharmaceutical company.
• Deal broadens laboratory testing services to support preclinical and clinical oncology development using DiviTum TKa for sample analysis.
• Scope extends beyond research-use-only work, creating a framework intended to streamline future work orders in pharma services.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biovica International AB published the original content used to generate this news brief on July 07, 2026, and is solely responsible for the information contained therein.